Owens & Minor (OMI) Competitors $6.66 -0.27 (-3.83%) Closing price 03:59 PM EasternExtended Trading$7.31 +0.66 (+9.90%) As of 05:26 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock OMI vs. MCK, COR, CAH, HSIC, PDCO, ALVO, LFST, APLS, SRRK, and ACHCShould you be buying Owens & Minor stock or one of its competitors? The main competitors of Owens & Minor include McKesson (MCK), Cencora (COR), Cardinal Health (CAH), Henry Schein (HSIC), Patterson Companies (PDCO), Alvotech (ALVO), LifeStance Health Group (LFST), Apellis Pharmaceuticals (APLS), Scholar Rock (SRRK), and Acadia Healthcare (ACHC). These companies are all part of the "medical" sector. Owens & Minor vs. McKesson Cencora Cardinal Health Henry Schein Patterson Companies Alvotech LifeStance Health Group Apellis Pharmaceuticals Scholar Rock Acadia Healthcare Owens & Minor (NYSE:OMI) and McKesson (NYSE:MCK) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, analyst recommendations, institutional ownership, community ranking, media sentiment, dividends, profitability, valuation and risk. Does the media favor OMI or MCK? In the previous week, McKesson had 45 more articles in the media than Owens & Minor. MarketBeat recorded 59 mentions for McKesson and 14 mentions for Owens & Minor. McKesson's average media sentiment score of 1.42 beat Owens & Minor's score of 1.13 indicating that McKesson is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Owens & Minor 7 Very Positive mention(s) 3 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive McKesson 47 Very Positive mention(s) 4 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Does the MarketBeat Community believe in OMI or MCK? McKesson received 719 more outperform votes than Owens & Minor when rated by MarketBeat users. Likewise, 74.20% of users gave McKesson an outperform vote while only 47.94% of users gave Owens & Minor an outperform vote. CompanyUnderperformOutperformOwens & MinorOutperform Votes25647.94% Underperform Votes27852.06% McKessonOutperform Votes97574.20% Underperform Votes33925.80% Do institutionals & insiders believe in OMI or MCK? 98.0% of Owens & Minor shares are owned by institutional investors. Comparatively, 85.1% of McKesson shares are owned by institutional investors. 3.6% of Owens & Minor shares are owned by company insiders. Comparatively, 0.1% of McKesson shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Which has preferable earnings & valuation, OMI or MCK? McKesson has higher revenue and earnings than Owens & Minor. Owens & Minor is trading at a lower price-to-earnings ratio than McKesson, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOwens & Minor$10.70B0.05-$41.30M-$4.72-1.41McKesson$344.58B0.25$3.00B$21.8431.70 Which has more risk and volatility, OMI or MCK? Owens & Minor has a beta of 1.02, meaning that its stock price is 2% more volatile than the S&P 500. Comparatively, McKesson has a beta of 0.49, meaning that its stock price is 51% less volatile than the S&P 500. Do analysts rate OMI or MCK? Owens & Minor presently has a consensus price target of $13.75, indicating a potential upside of 106.61%. McKesson has a consensus price target of $668.50, indicating a potential downside of 3.46%. Given Owens & Minor's higher probable upside, research analysts clearly believe Owens & Minor is more favorable than McKesson.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Owens & Minor 2 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.00McKesson 0 Sell rating(s) 3 Hold rating(s) 12 Buy rating(s) 1 Strong Buy rating(s) 2.88 Is OMI or MCK more profitable? McKesson has a net margin of 0.82% compared to Owens & Minor's net margin of -0.46%. Owens & Minor's return on equity of 14.60% beat McKesson's return on equity.Company Net Margins Return on Equity Return on Assets Owens & Minor-0.46% 14.60% 2.51% McKesson 0.82%-181.26%5.34% SummaryMcKesson beats Owens & Minor on 14 of the 19 factors compared between the two stocks. Remove Ads Get Owens & Minor News Delivered to You Automatically Sign up to receive the latest news and ratings for OMI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OMI vs. The Competition Export to ExcelMetricOwens & MinorMedical & hospital equipment IndustryMedical SectorNYSE ExchangeMarket Cap$514.13M$7.88B$5.33B$18.52BDividend YieldN/A1.98%5.11%4.23%P/E Ratio-10.2421.1121.7331.15Price / Sales0.051.19379.2025.69Price / Cash1.2510.7638.1517.53Price / Book0.552.106.464.29Net Income-$41.30M$259.21M$3.20B$1.02B7 Day Performance-14.68%-1.92%6.54%6.59%1 Month Performance-29.19%-8.94%-8.55%-6.88%1 Year Performance-73.37%-11.01%10.33%1.23% Owens & Minor Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OMIOwens & Minor4.7932 of 5 stars$6.66-3.8%$13.75+106.6%-72.9%$514.13M$10.70B-10.2422,500Positive NewsMCKMcKesson4.5845 of 5 stars$661.26-3.2%$661.000.0%+32.7%$82.87B$344.58B30.2875,000Positive NewsHigh Trading VolumeCORCencora4.2019 of 5 stars$274.60-1.4%$280.20+2.0%+21.5%$53.25B$638.56M39.0642,000Positive NewsCAHCardinal Health4.6234 of 5 stars$125.74-3.0%$140.14+11.5%+28.2%$30.37B$222.28B23.4646,500Short Interest ↓Positive NewsHigh Trading VolumeHSICHenry Schein4.0339 of 5 stars$64.31-1.8%$81.10+26.1%-7.6%$7.99B$12.67B26.4722,000Analyst RevisionNews CoverageGap DownPDCOPatterson Companies3.3581 of 5 stars$30.85-0.3%$26.57-13.9%+23.1%$2.73B$6.51B18.047,600Analyst ForecastShort Interest ↑Analyst RevisionNews CoverageHigh Trading VolumeALVOAlvotech1.7084 of 5 stars$8.32-2.1%$18.00+116.3%-30.3%$2.51B$489.68M-4.501,026Analyst RevisionGap DownLFSTLifeStance Health Group1.9107 of 5 stars$6.51-2.0%$8.50+30.6%+13.2%$2.50B$1.25B-25.046,640Positive NewsGap DownAPLSApellis Pharmaceuticals4.1441 of 5 stars$19.80-0.9%$45.59+130.2%-62.7%$2.49B$781.37M-9.75770Gap DownSRRKScholar Rock3.8819 of 5 stars$26.04-3.2%$42.67+63.9%+115.1%$2.47B$33.19M-11.08140Positive NewsACHCAcadia Healthcare4.4655 of 5 stars$26.42-3.5%$52.19+97.5%-63.9%$2.45B$3.15B8.6623,500 Remove Ads Related Companies and Tools Related Companies McKesson Alternatives Cencora Alternatives Cardinal Health Alternatives Henry Schein Alternatives Patterson Companies Alternatives Alvotech Alternatives LifeStance Health Group Alternatives Apellis Pharmaceuticals Alternatives Scholar Rock Alternatives Acadia Healthcare Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:OMI) was last updated on 4/15/2025 by MarketBeat.com Staff From Our Partners[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Owens & Minor, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Owens & Minor With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.